Dr. Stadler is an Attending Physician and Clinic Director of the Clinical Genetics Service with a secondary appointment in the Gastrointestinal Medical Oncology Service at Memorial Sloan-Kettering Cancer Center (MSK). Her clinical focus is on the diagnosis, treatment, and management of patients and families with an inherited genetic predisposition to gastrointestinal cancers with a special focus on Lynch syndrome. Her research interests focus on the identification of new cancer susceptibility genes through the use of genomic technologies and the development of novel approaches to cancer screening and prevention in high-risk families. She serves as co-PI of MSK’s tumor-normal IMPACT sequencing protocol overseeing agnostic germline sequencing encompassing over >50,000 cancer patients, for which she and her colleagues were awarded the 2025 Team Science Award by AACR. She has been the PI of numerous projects with funding from the National Institute of Health, Damon Runyon Cancer Research Foundation, Cycle for Survival, Marks Foundation, Starr Cancer Consortium, and the Romeo Milio Lynch Syndrome Foundation. She has published and lectured internationally on cancer genetic syndromes and she currently serves as Associate Editor of JCO Precision Oncology and as Section Editor for UpToDate. She has been recognized as a Top Doctor in New York Magazine annually since 2019 and has been a recipient of the Exceptional Women In Medicine Award via Castle Connolly since 2019.